Autoimmune Diseases  >>  Actemra IV (tocilizumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Actemra IV (tocilizumab) / Roche, JW Pharma
NCT00365001: A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.

Completed
1
23
US, RoW
tocilizumab [RoActemra/Actemra], Methotrexate, Simvastatin
Hoffmann-La Roche
Rheumatoid Arthritis
 
04/08
NCT02097524: Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

Checkmark ACR 2015: ASCERTAIN and Study 1309 trials
Nov 2015 - Nov 2015: ACR 2015: ASCERTAIN and Study 1309 trials
Checkmark ACR-ARHP 2015: Study 1309
Oct 2015 - Oct 2015: ACR-ARHP 2015: Study 1309
Completed
1
105
US
Sarilumab, REGN88, SAR153191, Tocilizumab
Regeneron Pharmaceuticals, Sanofi
Rheumatoid Arthritis
04/15
04/15

Download Options